This book reports innovations in the preclinical study of stroke, including - novel tools and findings in animal models of stroke, - novel biochemical mechanisms through which ischemic damage may be both generated and limited, - novel pathways to neuroprotection. Although hypothermia has been so far the sole "neuroprotection" treatment that has survived the translation from preclinical to clinical studies, progress in both preclinical studies and in the design of clinical trials will hopefully provide more and better treatments for ischemic stroke. This book aims at providing the preclinical scientist with innovative knowledge and tools to investigate novel mechanisms of, and treatments for, ischemic brain damage
Stroke continues to be a significant cause of death and disability worldwide. Although major advance...
Acute ischemic stroke is a devastating cause of death and disability, consequences of which depend o...
The past decade has brought tremendous progress in diagnostic and therapeutic options for cerebrovas...
Pharmacological Neuroprotection in Stroke: Rationale, State-of-the-art and Future Directions Ischemi...
Translation from bench to bedside is a tremendous chal-lenge for stroke researchers. Effective neuro...
IMPORTANCE: Preclinical stroke research has had a remarkably low translational success rate, and the...
Stroke remains a disease with a serious impact on quality of life but few effective treatments exist...
Neuroprotection aims to prevent salvageable neurons from dying. Despite showing efficacy in experime...
Neuroprotection aims to prevent salvageable neurons from dying. Despite showing efficacy in experime...
In recent years research on ischemic stroke has developed powerful therapeutic tools. The novel fron...
Drugs that dissolve clots, such as streptokinase and rTPA, and drugs that promote vasodilation are u...
Ischemic brain damage represents a major source of morbidity and mortality in westernized society an...
Abstract Despite the impressive efficacies demonstrated in preclinical research, hundreds of potenti...
Experimental evidence shows that therapeutic hypothermia (TH) protects the brain from cerebral injur...
The past decade has brought tremendous progress in diagnostic and therapeutic options for cerebrovas...
Stroke continues to be a significant cause of death and disability worldwide. Although major advance...
Acute ischemic stroke is a devastating cause of death and disability, consequences of which depend o...
The past decade has brought tremendous progress in diagnostic and therapeutic options for cerebrovas...
Pharmacological Neuroprotection in Stroke: Rationale, State-of-the-art and Future Directions Ischemi...
Translation from bench to bedside is a tremendous chal-lenge for stroke researchers. Effective neuro...
IMPORTANCE: Preclinical stroke research has had a remarkably low translational success rate, and the...
Stroke remains a disease with a serious impact on quality of life but few effective treatments exist...
Neuroprotection aims to prevent salvageable neurons from dying. Despite showing efficacy in experime...
Neuroprotection aims to prevent salvageable neurons from dying. Despite showing efficacy in experime...
In recent years research on ischemic stroke has developed powerful therapeutic tools. The novel fron...
Drugs that dissolve clots, such as streptokinase and rTPA, and drugs that promote vasodilation are u...
Ischemic brain damage represents a major source of morbidity and mortality in westernized society an...
Abstract Despite the impressive efficacies demonstrated in preclinical research, hundreds of potenti...
Experimental evidence shows that therapeutic hypothermia (TH) protects the brain from cerebral injur...
The past decade has brought tremendous progress in diagnostic and therapeutic options for cerebrovas...
Stroke continues to be a significant cause of death and disability worldwide. Although major advance...
Acute ischemic stroke is a devastating cause of death and disability, consequences of which depend o...
The past decade has brought tremendous progress in diagnostic and therapeutic options for cerebrovas...